期刊文献+

去势抵抗型前列腺癌治疗新进展 被引量:6

下载PDF
导出
摘要 前列腺癌作为男性常见肿瘤之一,其发生机制尚未完全清楚。内分泌治疗仍是晚期前列腺癌主要的治疗方法,但大多数患者在经过14~30个月的治疗后逐渐发展为去势抵抗型前列腺癌( CRPC),成为治疗的一大难题。随着几种新型药物的获批,CRPC的治疗也进入了新的阶段。现主要介绍了CRPC的概念、形成机制及主要治疗方法,并重点从药物作用机制及临床实验结果对药物治疗CRPC的新进展作一综述,包括抗雄激素药物、免疫制剂、分子靶向药物及其各自的代表药物如阿比特龙、Sipuleucel-T、BIBF-1120等,为晚期前列腺癌的治疗提供新的选择。
出处 《安徽医科大学学报》 CAS 北大核心 2014年第2期276-279,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金面上项目(编号:81370856)
  • 相关文献

参考文献28

  • 1Aneja S, Pratiwadi It R, Yu J B. ttypofractionated radiation ther- apy for prnstate cancer: risks and potential benefits in a fiscally conservative health care system[J]. Ontology (Williston Park), 2012, 26(6) : 512 -8.
  • 2Heidenrieh A, Belhnunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically loealised disease [J]. Actas Urol Esp, 2011 . 35 ( 9 ) :501 -14.
  • 3Locke J A, Guns E S, Lubik A A, et al. Androgen levels increase by intratumoral de novo steroidogenesis during progression of cas- tration-resistant prostate cancer[ J ]. Cancer Res, 2008, 68 ( 15 ) : 6407 - 15.
  • 4Mukherjee R, McGuinness O H, McCall P, et al. Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer[J]. Br J Cancer, 2011, 104(12) : 1920 - 8.
  • 5Brand L J, Dehm S M. Androgen receptor gene rearrangements: new perspectives on prostate cancer progression [ J ]. Curr Drug Targets, 2013, 14(4) :441 -9.
  • 6Zielinski R R, Eiql B J, Chi K N. Targeting the apoptosis path- way in prostate cancer[ J ]. Cancer J, 2013, 19 ( 1 ) : 79 - 89.
  • 7Bitting R L, Armstrong A J. Targeting the PI3K/Akt/mTOR path- way in castration-resistant prostate cancer[ J]. Endocr Relat Canc- er, 2013, 20(3) : 83 -99.
  • 8Qi w, Cooke L S, Stejskal A, et al. MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/P13K/Akt pathway and tumor growth in prostate canc- er[ J ]. BMC Ca 2009, 11 (9) : 142.
  • 9Shen M M, Wang X, Eeonomides K D, et al. Progenitor cells for the prostate epithelium: roles in development, regeneration, and cancer [ J ]. Cold Spring Harb Syrnp Quant Biol, 2008, 73 : 529 - 38.
  • 10de Bono J S, Logothetis C J,Molina A,et al. Abiraterone and in- creased survival in metastatic prostate cancer [ J]. N Engl J Med, 2011,364(21) : 1995 -2005.

同被引文献38

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部